- Home
- MRVI vs CSTL Comparison
MRVI vs CSTL Comparison
Compare MRVI & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- CSTL
- Stock Information
- Founded
- MRVI 2020
- CSTL 2007
- Country
- MRVI United States
- CSTL United States
- Employees
- MRVI N/A
- CSTL N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- CSTL Medical Specialities
- Sector
- MRVI Health Care
- CSTL Health Care
- Exchange
- MRVI Nasdaq
- CSTL Nasdaq
- Market Cap
- MRVI 809.2M
- CSTL 848.1M
- IPO Year
- MRVI 2020
- CSTL 2019
- Fundamental
- Price
- MRVI $5.58
- CSTL $27.39
- Analyst Decision
- MRVI Buy
- CSTL Strong Buy
- Analyst Count
- MRVI 11
- CSTL 6
- Target Price
- MRVI $10.03
- CSTL $39.67
- AVG Volume (30 Days)
- MRVI 1.6M
- CSTL 305.0K
- Earning Date
- MRVI 11-07-2024
- CSTL 11-04-2024
- Dividend Yield
- MRVI N/A
- CSTL N/A
- EPS Growth
- MRVI N/A
- CSTL N/A
- EPS
- MRVI N/A
- CSTL 0.21
- Revenue
- MRVI $276,920,000.00
- CSTL $311,878,000.00
- Revenue This Year
- MRVI N/A
- CSTL $51.36
- Revenue Next Year
- MRVI $3.41
- CSTL N/A
- P/E Ratio
- MRVI N/A
- CSTL $132.63
- Revenue Growth
- MRVI N/A
- CSTL 62.43
- 52 Week Low
- MRVI $4.28
- CSTL $16.97
- 52 Week High
- MRVI $11.56
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- MRVI 49.01
- CSTL 39.09
- Support Level
- MRVI $5.45
- CSTL $27.51
- Resistance Level
- MRVI $6.01
- CSTL $32.57
- Average True Range (ATR)
- MRVI 0.34
- CSTL 1.55
- MACD
- MRVI 0.12
- CSTL -0.23
- Stochastic Oscillator
- MRVI 63.43
- CSTL 17.49
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.